U.S. Real Estate Stock News

US technology stocks are stepping into a busy stretch, with the country’s 250th anniversary celebrations, Alphabet’s entry into the Dow Jones Industrial Average, fresh tech IPOs, the June jobs report, and central bank focus on AI all competing for attention. Together, these events could shift how money moves across large US tech companies, from long standing giants like Alphabet to relatively recent listings. This article walks through 3 US Technology Sector Stocks from the screener that...

On June 12, 2026, OGE Energy Corp. and subsidiary OG&E entered into second amended and restated unsecured five-year revolving credit agreements, each upsized to US$650 million and extendable to 2031, replacing their prior US$550 million facilities. The expanded, ratings-linked facilities enhance liquidity and refinancing flexibility across the group, potentially supporting future capital needs such as infrastructure investments, acquisitions, and commercial paper back-up. Next, we’ll examine...

Align Technology announced that long-time Chairman C. Raymond Larkin, Jr. retired from the Chair role on July 1, 2026, with independent director Kevin Conroy assuming the position while Larkin remains on the Board through December 31, 2026 to support the transition. The appointment of Conroy, who led Exact Sciences to US$3.25 billion in annual revenue and now also serves on Abbott Laboratories’ board, introduces a healthcare veteran with deep commercialization and governance experience to...

F&G Annuities & Life (FG) stock is in focus after the company announced a leadership transition, with CEO Chris Blunt set to retire and President and CFO Conor Murphy moving into the CEO and President roles. See our latest analysis for F&G Annuities & Life. At a share price of $27.02, F&G Annuities & Life has seen a 1-day share price return of 2.0% following the CEO and CFO succession news, although its year to date share price return is down 10.05% and its 1-year total shareholder return is...

Mobileye Global (MBLY) has outlined plans to move beyond supplying autonomous driving technology and into running its own robotaxi service, with a fully owned ride hailing business targeted to launch in a U.S. city in 2027. See our latest analysis for Mobileye Global. Despite the new robotaxi initiative, Mobileye Global’s share price has fallen 24.47% over the past month and is down 30.45% year to date. The 1 year total shareholder return has declined 57.42%, suggesting recent enthusiasm has...

Euronet Worldwide (EEFT) is drawing attention after recent trading left the stock around $70.43. This is prompting investors to recheck its fundamentals, recent share performance over the past month and past 3 months, and valuation signals. See our latest analysis for Euronet Worldwide. Recent trading has been choppy for Euronet Worldwide, with a 5.03% 1 day share price return and a 6.97% 7 day share price return. However, the 1 year total shareholder return is down 30.84%, indicating that...

Earlier this month, Camden Property Trust’s Board of Trust Managers declared a second-quarter cash dividend of US$1.06 per share, payable on July 17, 2026 to shareholders of record as of June 30, 2026. This dividend affirmation underscores management’s focus on cash returns to investors while contending with elevated apartment supply, softer rents, and higher debt. Now we’ll examine how sustaining this US$1.06 dividend aligns with Camden’s capital recycling, Sunbelt exposure, and overall...

Zillow Group (ZG) is rolling out a personalized home buying and selling hub just as average 30 year mortgage rates in its marketplace slip to 6.17%, linking new digital tools with slightly easier financing conditions. See our latest analysis for Zillow Group. Zillow Group's recent product launches come at a time when the stock has a 1 day share price return of 7.0%, but the 1 year total shareholder return is down 54.28%, pointing to short term momentum after a prolonged period of weaker...

GeneDx Holdings recently appointed Mark Gardner as President, effective June 15, 2026, reporting to CEO Katherine Stueland and leading the company’s commercial and operations teams to strengthen execution and scale genomic medicine offerings. Gardner’s background running genomics and oncology businesses at Quest Diagnostics, OmniSeq, Thermo Fisher Scientific and Life Technologies adds deep operational and precision-medicine expertise to GeneDx’s leadership bench. We’ll now examine how...

Recent Performance Snapshot for A10 Networks A10 Networks (ATEN) has attracted fresh attention after a strong stretch in the stock, with the price closing at $34.98. Investors are weighing this move against the company’s recent financial profile and returns. See our latest analysis for A10 Networks. The recent move to a share price of $34.98 comes after a 16.06% 1 month share price return and a 101.61% year to date share price return. The 1 year total shareholder return stands at 85.16%,...

Cybin (HELP) is drawing fresh attention after reporting that enrollment in its APPROACH Phase 3 trial for HLP003 in major depressive disorder has surpassed 86%, a key marker in its broader PARADIGM program. See our latest analysis for Cybin. The recent APPROACH trial update comes after a sharp short term rebound in Cybin's 1 week and 1 month share price returns of 38.76% and 42.42% respectively. This is set against a year to date share price return that is still down 21.74% and a 5 year total...

Earlier this year, Alpha and Omega Semiconductor highlighted its pivot toward advanced computing systems and rising engagements with major cloud and hyperscale partners in AI power solutions. This deeper role in AI infrastructure suggests the company is increasingly positioned as a key supplier of medium-voltage technology to large-scale computing customers. Next, we’ll examine how this expanding hyperscale AI engagement could reshape Alpha and Omega Semiconductor’s existing investment...

How W. P. Carey Stock Has Been Performing W. P. Carey (WPC) trades around $73.86, with recent returns mixed across time frames. The stock is up over the past week and past 3 months, but slightly down over the past month. Over longer horizons, W. P. Carey shows positive total returns year to date, over the past year, and across the past 3 and 5 years, offering investors a track record to compare with other real estate income options. See our latest analysis for W. P. Carey. Recent trading in...

Earlier in June 2026, Coursera issued full-year 2026 guidance, projecting reported revenue between US$1.21 billion and US$1.24 billion, alongside normalized revenue expectations of US$1.49 billion to US$1.52 billion reflecting modest Enterprise growth and a Consumer segment decline due to transactional headwinds and paid marketing optimization. Following this guidance and the company’s post-merger update, analysts raised earnings estimates and expressed stronger confidence in Coursera’s...

Earlier in June 2026, C3.ai board member Jim H. Snabe took a leave of absence to serve as Special Envoy to the European Commission for Industrial Artificial Intelligence, stepping back from his board vote and advisory duties while remaining expected to return after his envoy role ends. His appointment places a long-serving C3.ai insider at the center of European industrial AI policymaking, potentially giving the company early insight into evolving regulations and enterprise requirements...

Recent share performance and what it tells you Avnet (AVT) has moved sharply in recent periods, with the stock up 75.1% year to date and 67.9% over the past year. The past month shows a relatively flat return near 0.6%. See our latest analysis for Avnet. Recent trading has been choppy for Avnet, with the share price down 4.9% on the day and 5.6% over the past week. However, the 90 day share price return of 47.4% and 1 year total shareholder return of 67.9% still point to strong underlying...

Steel Dynamics (STLD) stock has drawn fresh attention after recent trading performance, with the share price at $245.49 and mixed short term returns that contrast with stronger outcomes over the past year. See our latest analysis for Steel Dynamics. Recent trading has cooled, with the share price down 5.64% over the past month. However, Steel Dynamics still shows strong momentum when looking at the 42.91% 90 day share price return and 89.63% 1 year total shareholder return. If you are...

With global data sending mixed signals, from resilient Chinese manufacturing and shifting bond yields to uneven consumer confidence, many investors are looking for companies where analysts still expect clear earnings growth and balance sheet strength. That is where the Healthy high growth potential screener comes in, filtering for stocks that combine analyst-backed earnings growth expectations over the next 3 years with solid financial footing. In this article, you will see 3 stocks from this...

LyondellBasell Industries (LYB) has moved into focus after receiving a Zacks Rank #1 rating, a shift driven by higher earnings estimates, growth indicators and a dividend yield that stands out in its sector. See our latest analysis for LyondellBasell Industries. Despite the positive earnings revisions and Zacks Rank upgrade, LyondellBasell Industries has seen its share price fall 16.38% over the past month and 32.35% over the past quarter, while the 1 year total shareholder return of 2.33%...

Ligand Pharmaceuticals recently completed a US$625,000,000 Rule 144A offering of zero-coupon, senior unsecured convertible notes due September 15, 2031, following a broader US$1,000,000,000 shelf registration for equity and related securities. A key aspect of this financing is Ligand’s plan to pair the convertible notes with call spreads and share repurchases, aiming to manage potential dilution while preserving flexibility for acquisitions such as the previously announced XOMA Royalty...

Recently, commentary on Genuine Parts highlighted that its annual sales growth, same-store sales over the past two years, and operating margin have all lagged key industry peers, raising fresh questions about its competitive performance. This combination of softer sales metrics and below-average profitability has sharpened investor focus on whether Genuine Parts can reliably generate incremental demand and sustain earnings quality in a tougher operating backdrop. We’ll now explore how...

Ituran Location and Control (NasdaqGS:ITRN) has drawn renewed investor attention after a recent share price pullback, with the stock down 7% over the past week and 7% over the past month. See our latest analysis for Ituran Location and Control. Despite the recent 7% pullback over the past week, Ituran Location and Control still reflects strong momentum, with the 90 day share price return at 26.66% and the 1 year total shareholder return at 71.34%. If you are weighing Ituran Location and...

Pfizer (PFE) is in focus after investors were hit with mixed oncology news, a planned CFO transition, and fresh questions around its pipeline, all set against the backdrop of patent expirations and restructuring efforts. See our latest analysis for Pfizer. At a share price of $24.29, Pfizer has seen weaker momentum in recent months, with a 30 day share price return of 7.22% and a 90 day share price return of 12.53% despite oncology updates, legal clarity around Paxlovid, and a confirmed...

BioMarin Pharmaceutical (BMRN) is back in focus after new VOXZOGO and BMN 333 data at ENDO 2026, adding fresh context to a stock that recently reacted to mixed quarterly results and updated guidance. See our latest analysis for BioMarin Pharmaceutical. Alongside the ENDO 2026 update and a recent quarter that was mixed but included higher guidance, BioMarin Pharmaceutical’s share price shows short-term momentum building, with a 7.88% seven-day share price return and a 7.68% 90-day share price...